State-of-the-Art Review: Use of Antimicrobials at the End of Life

Author:

Karlin Daniel1ORCID,Pham Christine23,Furukawa Daisuke4,Kaur Ishminder5,Martin Emily1,Kates Olivia6,Vijayan Tara2

Affiliation:

1. Division of General Internal Medicine, Department of Medicine, University of California , Los Angeles, California , USA

2. Division of Infectious Diseases, Department of Medicine, University of California , Los Angeles, California , USA

3. Department of Pharmaceutical Services, University of California , Los Angeles, California , USA

4. Division of Infectious Diseases, Department of Medicine, Stanford University , Palo Alto, California , USA

5. Division of Infectious Diseases, Department of Pediatrics, University of California , Los Angeles, California , USA

6. Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland , USA

Abstract

Abstract Navigating antibiotics at the end of life is a challenge for infectious disease (ID) physicians who remain deeply committed to providing patient-centered care and engaging in shared decision making. ID physicians, who often see patients in both inpatient and outpatient settings and maintain continuity of care for patients with refractory or recurrent infections, are ideally situated to provide guidance that aligns with patients’ goals and values. Complex communication skills, including navigating difficult emotions around end-of-life care, can be used to better direct shared decision making and assist with antibiotic stewardship.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference35 articles.

1. Emotions and medical decision-making;Gengler;Soc Psychol Q,2020

2. Beyond the NURSE acronym: the functions of empathy in serious illness conversations;Childers;J Pain Symptom Manage,2023

3. Antibiotics are often used at the end of life, but at what cost?;Sullivan;Health Affairs,2018

4. Oral is the new IV. Challenging decades of blood and bone infection dogma: a systematic review;Wald-Dickler;Am J Med,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3